Condition

Hair Loss

Early-stage research in androgenetic alopecia.

Level C· Early human research exploring benefits

Quick summary

  • • Measured by trichoscopic hair density
  • • Follow-up is often only 3–6 months

Overview

Androgenetic alopecia is common and already has standard treatments.

Mechanisms studied

Perifollicular circulation and growth factors are studied.

Human research

Few studies compare with PRP.

Safety

Reported adverse events are mostly local — swelling, pain, or bruising at the harvest and injection sites. Infection and cell-processing quality remain the key risks to monitor.

Evidence limitations

Existing studies are limited by sample size, methodology, and follow-up, and SVF preparation differs substantially between centres, making cross-study comparison difficult.

Related research

Latest PubMed research

275 indexed studies for this condition · auto-updated 17 August 2026

View all

Last updated: 2026-06-18 · arisa-w